<DOC>
	<DOCNO>NCT01221948</DOCNO>
	<brief_summary>The purpose study document patient outcome , include effectiveness , safety , health economic data , Boston Scientific implantable deep brain stimulation ( DBS ) Vercise™ system bilateral stimulation subthalamic nucleus ( STN ) treatment moderate severe idiopathic Parkinson 's Disease ( PD ) .</brief_summary>
	<brief_title>Vercise Implantable Stimulator Treating Parkinson 's Disease</brief_title>
	<detailed_description>This multi-center , prospective , open label , non-randomized study use within-patient control ( patient serve his/her control ) document patient outcome , include effectiveness , safety , health economic data Boston Scientific implantable deep brain stimulation ( DBS ) Vercise™ system bilateral stimulation subthalamic nucleus ( STN ) treatment moderate severe idiopathic Parkinson 's Disease ( PD ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Key 1 . Diagnosis bilateral idiopathic PD presence least 2 follow : rest tremor , rigidity , bradykinesia . 2 . Duration bilateral idiopathic PD five year . 3 . Stable medication 4 . UPDRS subset III score ≥30 without medication . 5 . Lack dementia depression . 6 . Must improve antiparkinsonian medication , motor complication well control medication . 7 . Must appropriate candidate surgical procedure require bilateral STN DBS . 8 . Is willing able comply visit study related procedure 9 . Patient understand study requirement treatment procedure provide write informed consent studyspecific test procedure perform . Key 1 . Any intracranial abnormality medical condition would contraindicate DBS surgery . 2 . Any finding neuropsychological screening assessment would contraindicate DBS surgery , include dementia . 3 . Any significant psychiatric problem , include unrelated clinically significant depression . 4 . Any current drug alcohol abuse . 5 . Any history recurrent unprovoked seizure . 6 . Frequent fall receive good medication therapy without dyskinesia ( onstate ) . 7 . Any prior movement disorder treatment involve intracranial surgery device implantation . 8 . Any active implanted device . 9 . Any previous brain surgery would interfere placement lead function device . 10 . A history neurostimulation intolerance area body . 11 . A condition require likely require use magnetic resonance imaging ( MRI ) diathermy . 12 . Currently anticoagulant medication discontinue perioperative period . 13 . Have significant medical condition likely interfere study procedure likely confound evaluation study endpoint , include terminal illness survival &lt; 12 month . 14 . Participation another drug , device , biologics trial concurrently within precede 30 day . Any trial participation approve Principal Investigators . 15 . A female breastfeeding child bear potential positive urine pregnancy test use adequate contraception .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>